Literature DB >> 24313986

Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study (WIHS).

Ca Peralta1, R Scherzer, C Grunfeld, A Abraham, Pc Tien, P Devarajan, M Bennett, Aw Butch, K Anastos, Mh Cohen, M Nowicki, A Sharma, Ma Young, Mj Sarnak, Cr Parikh, Mg Shlipak.   

Abstract

OBJECTIVES: Chronic kidney disease (CKD) is common in HIV-infected individuals, and is associated with mortality in both the HIV-infected and general populations. Urinary markers of tubular injury have been associated with future kidney disease risk, but associations with mortality are unknown.
METHODS: We evaluated the associations of urinary interleukin-18 (IL-18), liver fatty acid binding protein (L-FABP), kidney injury molecule-1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL) and the albumin-to-creatinine ratio (ACR) with 10-year, all-cause death in 908 HIV-infected women. Serum cystatin C was used to estimate the glomerular filtration rate (eGFRcys).
RESULTS: There were 201 deaths during 9269 person-years of follow-up. After demographic adjustment, compared with the lowest tertile, the highest tertiles of IL-18 [hazard ratio (HR) 2.54; 95% confidence interval (CI) 1.75-3.68], KIM-1 (HR 2.04; 95% CI 1.44-2.89), NGAL (HR 1.50; 95% CI 1.05-2.14) and ACR (HR 1.63; 95% CI 1.13-2.36) were associated with higher mortality. After multivariable adjustment including adjustment for eGFRcys, only the highest tertiles of IL-18 (HR 1.88; 95% CI 1.29-2.74) and ACR (HR 1.46; 95% CI 1.01-2.12) remained independently associated with mortality. Findings for KIM-1 were borderline (HR 1.41; 95% CI 0.99-2.02). We found a J-shaped association between L-FABP and mortality. Compared with persons in the lowest tertile, the HR for the middle tertile of L-FABP was 0.67 (95% CI 0.46-0.98) after adjustment. Associations were stronger when IL-18, ACR and L-FABP were simultaneously included in models.
CONCLUSIONS: Among HIV-infected women, some urinary markers of tubular injury are associated with mortality risk, independently of eGFRcys and ACR. These markers represent potential tools with which to identify early kidney injury in persons with HIV infection.
© 2013 British HIV Association.

Entities:  

Keywords:  HIV; interleukin-18; kidney injury molecule-1; liver fatty acid binding protein; neutrophil gelatinase-associated lipocalin; urinary biomarkers

Mesh:

Substances:

Year:  2013        PMID: 24313986      PMCID: PMC3975680          DOI: 10.1111/hiv.12113

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  36 in total

1.  Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study.

Authors:  Thomas L Nickolas; Kai M Schmidt-Ott; Pietro Canetta; Catherine Forster; Eugenia Singer; Meghan Sise; Antje Elger; Omar Maarouf; David Antonio Sola-Del Valle; Matthew O'Rourke; Evan Sherman; Peter Lee; Abdallah Geara; Philip Imus; Achuta Guddati; Allison Polland; Wasiq Rahman; Saban Elitok; Nasir Malik; James Giglio; Suzanne El-Sayegh; Prasad Devarajan; Sudarshan Hebbar; Subodh J Saggi; Barry Hahn; Ralph Kettritz; Friedrich C Luft; Jonathan Barasch
Journal:  J Am Coll Cardiol       Date:  2012-01-17       Impact factor: 24.094

2.  Renal epithelium is a previously unrecognized site of HIV-1 infection.

Authors:  Leslie A Bruggeman; Michael D Ross; Nozomu Tanji; Andrea Cara; Steven Dikman; Ronald E Gordon; Godfrey C Burns; Vivette D D'Agati; Jonathan A Winston; Mary E Klotman; Paul E Klotman
Journal:  J Am Soc Nephrol       Date:  2000-11       Impact factor: 10.121

3.  Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons.

Authors:  Andy Choi; Rebecca Scherzer; Peter Bacchetti; Phyllis C Tien; Michael S Saag; Cynthia L Gibert; Lynda A Szczech; Carl Grunfeld; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2010-08-14       Impact factor: 8.860

4.  Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.

Authors:  Davide Bolignano; Antonio Lacquaniti; Giuseppe Coppolino; Valentina Donato; Susanna Campo; Maria Rosaria Fazio; Giacomo Nicocia; Michele Buemi
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 8.237

5.  Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study.

Authors:  Michelle C Odden; Rebecca Scherzer; Peter Bacchetti; Lynda Anne Szczech; Stephen Sidney; Carl Grunfeld; Michael G Shlipak
Journal:  Arch Intern Med       Date:  2007-11-12

6.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

7.  IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation.

Authors:  Isaac E Hall; Sri G Yarlagadda; Steven G Coca; Zhu Wang; Mona Doshi; Prasad Devarajan; Won K Han; Richard J Marcus; Chirag R Parikh
Journal:  J Am Soc Nephrol       Date:  2009-09-17       Impact factor: 10.121

8.  Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy.

Authors:  Mardge H Cohen; Audrey L French; Lorie Benning; Andrea Kovacs; Kathryn Anastos; Mary Young; Howard Minkoff; Nancy A Hessol
Journal:  Am J Med       Date:  2002-08-01       Impact factor: 4.965

9.  Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study.

Authors:  Michael Bennett; Catherine L Dent; Qing Ma; Sudha Dastrala; Frank Grenier; Ryan Workman; Hina Syed; Salman Ali; Jonathan Barasch; Prasad Devarajan
Journal:  Clin J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 8.237

10.  Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons.

Authors:  Andy I Choi; Yongmei Li; Steven G Deeks; Carl Grunfeld; Paul A Volberding; Michael G Shlipak
Journal:  Circulation       Date:  2010-01-25       Impact factor: 29.690

View more
  23 in total

1.  Use of urine biomarker-derived clusters to predict the risk of chronic kidney disease and all-cause mortality in HIV-infected women.

Authors:  Rebecca Scherzer; Haiqun Lin; Alison Abraham; Heather Thiessen-Philbrook; Chirag R Parikh; Michael Bennett; Mardge H Cohen; Marek Nowicki; Deborah R Gustafson; Anjali Sharma; Mary Young; Phyllis Tien; Vasantha Jotwani; Michael G Shlipak
Journal:  Nephrol Dial Transplant       Date:  2016-01-10       Impact factor: 5.992

2.  Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Kathleen D Liu; Wei Yang; Alan S Go; Amanda H Anderson; Harold I Feldman; Michael J Fischer; Jiang He; Radhakrishna R Kallem; John W Kusek; Stephen R Master; Edgar R Miller; Sylvia E Rosas; Susan Steigerwalt; Kaixiang Tao; Matthew R Weir; Chi-Yuan Hsu
Journal:  Am J Kidney Dis       Date:  2014-10-11       Impact factor: 8.860

Review 3.  Emerging biomarkers of chronic kidney disease in children.

Authors:  Jason H Greenberg; Aadil Kakajiwala; Chirag R Parikh; Susan Furth
Journal:  Pediatr Nephrol       Date:  2017-06-17       Impact factor: 3.714

Review 4.  Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.

Authors:  Vasantha Jotwani; Mohamed G Atta; Michelle M Estrella
Journal:  J Am Soc Nephrol       Date:  2017-08-07       Impact factor: 10.121

5.  The association between urinary liver-type fatty acid-binding protein and chronic kidney disease classification in HIV-infected Japanese patients.

Authors:  Shinichi Hikasa; Megumi Yasuda; Kyoko Hideta; Mai Kawakami; Satoshi Higasa; Akihiro Sawada; Tazuko Tokugawa; Takeshi Kimura
Journal:  Clin Exp Nephrol       Date:  2016-10-19       Impact factor: 2.801

6.  Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study.

Authors:  Meyeon Park; Chi-Yuan Hsu; Alan S Go; Harold I Feldman; Dawei Xie; Xiaoming Zhang; Theodore Mifflin; Sushrut S Waikar; Venkata S Sabbisetti; Joseph V Bonventre; Josef Coresh; Robert G Nelson; Paul L Kimmel; John W Kusek; Mahboob Rahman; Jeffrey R Schelling; Ramachandran S Vasan; Kathleen D Liu
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-02       Impact factor: 8.237

Review 7.  Epidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patients.

Authors:  Minoru Ando; Naoki Yanagisawa
Journal:  World J Nephrol       Date:  2015-07-06

8.  Distinct Dimensions of Kidney Health and Risk of Cardiovascular Disease, Heart Failure, and Mortality.

Authors:  Alexandra K Lee; Ronit Katz; Vasantha Jotwani; Pranav S Garimella; Walter T Ambrosius; Alfred K Cheung; Lisa H Gren; Javier A Neyra; Henry Punzi; Kalani L Raphael; Michael G Shlipak; Joachim H Ix
Journal:  Hypertension       Date:  2019-08-05       Impact factor: 10.190

9.  Association of urinary injury biomarkers with mortality and cardiovascular events.

Authors:  Mark J Sarnak; Ronit Katz; Anne Newman; Tamara Harris; Carmen A Peralta; Prasad Devarajan; Michael R Bennett; Linda Fried; Joachim H Ix; Suzanne Satterfield; Eleanor M Simonsick; Chirag R Parikh; Michael G Shlipak
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

10.  Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation Trial.

Authors:  Nisha Bansal; Myra A Carpenter; Daniel E Weiner; Andrew S Levey; Marc Pfeffer; John W Kusek; Jianwen Cai; Lawrence G Hunsicker; Meyeon Park; Michael Bennett; Kathleen D Liu; Chi-Yuan Hsu
Journal:  J Am Soc Nephrol       Date:  2015-11-04       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.